Ana Pocivavsek to Prenatal Exposure Delayed Effects
This is a "connection" page, showing publications Ana Pocivavsek has written about Prenatal Exposure Delayed Effects.
Connection Strength
2.467
-
Prenatal Kynurenine Elevation Elicits Sex-Dependent Changes in Sleep and Arousal During Adulthood: Implications for Psychotic Disorders. Schizophr Bull. 2021 08 21; 47(5):1320-1330.
Score: 0.683
-
Inhibition of kynurenine aminotransferase II attenuates hippocampus-dependent memory deficit in adult rats treated prenatally with kynurenine. Hippocampus. 2019 02; 29(2):73-77.
Score: 0.566
-
Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats. Psychopharmacology (Berl). 2014 Jul; 231(14):2799-809.
Score: 0.407
-
Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood. Eur J Neurosci. 2012 May; 35(10):1605-12.
Score: 0.358
-
Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood. Psychopharmacology (Berl). 2018 03; 235(3):651-661.
Score: 0.131
-
Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding. Psychopharmacology (Berl). 2016 Oct; 233(21-22):3725-3735.
Score: 0.121
-
Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology. 2015 Mar; 90:33-41.
Score: 0.107
-
Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine. Neuroscience. 2013 May 15; 238:19-28.
Score: 0.095